Sign in
4

Changes in Ownership

Arcadia Biosciences, Inc. Filed Acc 0001209191-19-050493

Chief Executive Officer bought 2,000 shares at $5.25 ($10,500)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Plavan Matthew T Chief Executive Officer 2019-09-23 Purchase +2,000 $5.25 $10,500 12,000 D: show line 1 in the form
Open-market purchases · 2,000 sh · avg $5.25 · $10,500
Loading xslF345X03/doc4.xml…